A model of Helicobacter pylori persistence in a case of gastric cancer

New Microbiologica

Volumn 33, Issue 4, 2010, Pages 343-349

  Grande, Rossella ^a   Giulio, Mara Di ^a   Di Campli, Emanuela ^a   Bartolomeo, Soraya Di ^a   Cellini, Luigina ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

CagA status; Drug resistance; Helicobacter pylori; Mixed infection

Indexed keywords

HELICOBACTER PYLORI;

EID: 78650236792     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ARGENT R.H., ZHANG Y., ATHERTON J.C. (2005). Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. J. Clin. Microbiol. 2, 791-795.
2. BASSO D., ZAMBON C.F., LETLEY D.P., STRANGES A., MARCHET A., RHEAD J.L., SCHIAVON S., GUARISO G., CEROTI M., NITTI D., RUGGE M., PLEBANI M., ATHERTON J.C. (2008). Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology. 135, 91-99.
3. CELLINI L., DONELLI G. (2000). Virulence factors of Helicobacter pylori. Microb. Ecol. Health Dis. 12, 259-262.
4. CELLINI L., GRANDE R., DI CAMPU E., DI BARTOLOMEU S., CAPODICASA S., MARZIO L. (2006). Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. Scand. J. Gastroenterol. 13, 280-287.
5. CELLINI L., GRANDE R., DI CAMPLI E., DI BARTOLOMEU S., DI GIULIO M., TRAINI T., TRUBIANI O. (2008a). Characterization of an Helicobacter pylori environmental strain. J. Appl. Microbiol. 3, 761-769.
6. CELLINI L., GRANDE R., DI CAMPU E., TRAINI T., DI Giuuo M., LANNUTTI S.N., LATTANZIO R. (2008b). Dynamic colonization of Helicobacter pylori in human gastric mucosa Scand. J. Gastroenterol. 43, 178-185. (Pubitemid 351161521)
7. CHISHOLM S.A., TEARE E.L., PATEL B., OWEN R.J. (2002). Determination of Helicobacter pylori vacA allelic types by single-step multiplex PCR. Lett. Appl. Microbiol. 35, 42-46.
8. CLINICAL AND LABORATORY STANDARDS INSTITUTE. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement. (2005). Villanova, PA: CLSI; Publication No. M100-S15.
9. DRUMM B., SHERMAN P. (1989). Long-term storage of Campylobacter pylori. J. Clin. Microbiol. 27, 1655-1656.
10. FALUSH D., KRAFT C., TAYLOR N.S., CORREA P., FOX J.G., ACHTMAN M., SUERBAUM S. (2001). Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc. Natl. Acad. Sci. USA. 98, 15056-15061.
11. FIGUEIREDO C., MACHADO J.C., PHAROAH P., SERUCA R., SOUSA S., CARVALHO R., CAPELINHA A.F., QUINT W., CALDAS C., VAN DOORN L.J., CARNEIRO F., SOBRINHOSIMÕES M. (2002). Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 94, 1680-1687.
12. GIBSON J.R., SLATER E., XERRY J., TOMPKINS D.S., OWEN R.J. (1998). Use of an Amplified Fragment Length Polymorphism technique to fingerprint and differentiate isolates of Helicobacter pylori. J. Clin. Microbiol. 36, 2580-2585.
13. GERNER-SMIDT P., GRAVES L.M., HUNTER S., SWAMINATHAN B. (1998). Computerized analysis of restriction fragment length polymorphism patterns: comparative evaluation of two commercial software packages. J. Clin. Microbiol. 36, 1318-1323.
14. HUNG K.H., SHEU B.S., CHANG W.L., WU H.M., Liu C.C., Wu J.J. (2009). Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter. 14, 61-65.
15. ITO M., TAKATA S., TATSUGAMI M., WADA Y., IMAGAWA S., MATSUMOTO Y., TANAKA S., YOSHIHARA M., CHAYAMA K. (2009). Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J. Gastroenterol. 44, 365-371.
16. JAROSZ M., RYCHLIK E., SIUBA M., RESPONDER W., RYZKOSKIBA M., SAJÓR I., GUGABA S., BBAZEJCZYK T., CIOK J. (2009). Dietary and socio-economic factors in relation to Helicobacter pylori re-infection. World J. Gastroenterol. 15, 1119-1125.
17. JONES K.R., JOO Y.M., JANG S., YOO Y.J., LEE H.S., CHUNG I.S., OLSEN C.H., WHITMIRE J.M., MERRELL D.S., CHA J.H. (2009). Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J. Clin. Microbiol. 47, 959-968.
18. KERSULYTE D., CHALKAUSKAS H., BERG D.E. (1999). Emergence of recombinant strains of Helicobacter pylori during human infection. Mol. Microbiol. 31, 31-43.
19. KIM J.J., KIM JG, KWON D.H. (2003). Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter. 8, 202-206.
20. KRAFT C., STACK A., JOSENHANS C., NIEHUS E., DIETRICH G., CORREA P., FOX J.G., FALUSH D., SUERBAUM S. (2006). Genomic changes during chronic Helicobacter pylori infection. J. Bacteriol. 188, 249-254.
21. LEE S.A., KANG D., SHIM K.N., CHOE J.W., HONG W.S., CHOI H. (2003). Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J. Epidemiol. 13, 162-168. (Pubitemid 44143816)
22. MIEHLKE S., THOMAS R., GUITERREZ O., GRAHAM D.Y., GO M.F. (1999). DNA fingerprinting of single colonies of Helicobacter pylori from gastric cancer patients suggests infection with a single predominant strain. J. Clin. Microbiol. 37, 245-247.
23. RHEAD J.L., LETLEY D.R, MOHAMMADI M., HUSSEIN N., MOHAGHEGHI M.A., ESHAGH HOSSEINI M., ATHERTON J.C. (2007). A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 133, 926-936.
24. SCHWARZ S., MORELLI G., KUSECEK B., MANICA A., BALLOUX F., OWEN R.J., GRAHAM D.Y., VAN DER MERWE S., ACHTMAN M., SUERBAUM S. (2008). Horizontal versus familial transmission of Helicobacter pylori. PLos Pathog. 4, e1000180.
25. SGOURAS D.N., PANAYOTOPOULOU E.G., PAPADAKOS K., MARTINEZ-GONZALEZ B., ROUMBANI A., PANAYIOTOU J., VANVUET-CONSTANTINIDOU C., MENTIS A.F., ROMAGIANNIKOU E. (2009) CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children. J. Clin. Microbiol. 47, 2426-2434.
26. SUERBAUM S. (2000). Genetic variability within Helicobacter pylori. Int. J. Med. Microbiol. 290, 175-181.
27. SUERBAUM S., JOSENHANS C. Helicobacter pylori evolution and phenotypic diversification in a changing host. (2007). Nat. Rev. Microbiol. 5, 441-452.
28. TAYLOR D.E., EATON M., CHANG N., SALAMA S.M. (1992). Construction of a Helicobacter pylori genome map and demonstration of diversity at the genome level. J. Bacteriol. 174, 6800-6806.
29. TORACCHIO S., CAPODICASA S., SORAJA D.B., CELLINI L., MARZIO L. (2005). Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin. Dig. Liver Dis. 37, 33-38.
30. VAN DOORN L.J., FIGUEIREDO C., SANNA R., PLAISIER A., SCHNEEBERGERN P., DE BOER W., QUINT W. (1998). Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 115, 58-66.
31. WANG G., JIANG Q., TAYLOR D.E. (1998). Genotypic characterization of clarithromycin- resistant and susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. J. Clin. Microbiol. 36, 2730-2731.
32. WUEPPENHORST N., STUEGER H.P., KIST M., GLOCKER E. (2009). Identification and molecular characterization of triple and quadruple-resistant Helicobacter pylori clinical isolates in Germany. J. Antimicrob. Chemother. 63, 648-653.